TCTR20211111002
Completed
Phase 3
A study of onabotulinum toxin type A for the treatment of ultraviolet B-induced hyperpigmentation: a prospective, randomized, controlled trial
Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital0 sites15 target enrollmentNovember 11, 2021
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- VB-induced hyperpigmentation
- Sponsor
- Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Healthy subjects older than 18\-year\-old
Exclusion Criteria
- •the subjects who have the serious underlying diseases, pregnancy, active skin diseases, allergic reaction to BoNT\-A, history of photosensitive disorders, and ongoing use of topical medications or laser procedures at the experimental sites
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
To check wrinkle free forehead after injection of Botulinum drug.CTRI/2015/03/005613Dr L Krishna Prasad Head of department Department of oral and maxillofacial surgery
Completed
Not Applicable
Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014Japanese cedar pollinosisJPRN-UMIN000013007Saitama Medical University20
Not yet recruiting
Not Applicable
Assessment of Botulinum Toxin Type A in the Treatment of Hand EczemaPACTR201704002194318Dermatology Department, Faculty of Medicine, University of Alexandria60
Active, not recruiting
Phase 1
botulinum toxin for the treatment of chronic anal fissureChronic anal fissureTherapeutic area: Not possible to specifyEUCTR2017-001216-11-ESDra. A. Teresa Calderón Duque
Completed
Phase 3
The effect of botox in treatment of scarKeloid Lesion.Diseases of skin and soft tissueIRCT2016020926489N1School of Medicine, Tehran University of Medical Sciences86